(Q40371743)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16170366%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor imatinib and mutation of Asp-802 to Val confers resistance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16170366%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16170366%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Taylor JR

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16170366%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Domin J

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16170366%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Dibb NJ

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16170366%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

English

0 references

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16170366%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16170366%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16170366%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16170366%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

147-151

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16170366%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209007

7 January 2020

exact match

0 references

cites work

Regulation of microglia - potential new drug targets in the CNS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

A single amino acid exchange inverts susceptibility of related receptor tyrosine kinases for the ATP site inhibitor STI-571.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Protein kinases--the major drug targets of the twenty-first century?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Several Bcr-Abl kinase domain mutants associated with imatinib mesylate resistance remain sensitive to imatinib

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Imatinib inhibits the in vitro development of the monocyte/macrophage lineage from normal human bone marrow progenitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Switching on kinases: oncogenic activation of BRAF and the PDGFR family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Expression of v-fms and c-fms in the hemopoietic cell line FDC-P1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Management of malignant gastrointestinal stromal tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Isolation and characterization of a cloned growth factor dependent macrophage cell line, BAC1.2F5.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Cell specific transformation by c-fms activating loop mutations is attributable to constitutive receptor degradation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Directions of drug discovery in osteoporosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Role of colony-stimulating factor-1 in reproduction and development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Tumour-educated macrophages promote tumour progression and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Class III receptor tyrosine kinases: role in leukaemogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Induction of macrophage colony-stimulating factor-dependent growth and differentiation after introduction of the murine c-fms gene into FDC-P1 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Transforming potential of the c-fms proto-oncogene (CSF-1 receptor).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Evidence that downregulation of the M-CSF receptor is not dependent upon receptor kinase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

The v-fms oncogene induces factor-independent growth and transformation of the interleukin-3-dependent myeloid cell line FDC-P1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Activation of the feline c-fms proto-oncogene: multiple alterations are required to generate a fully transformed phenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209007

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16170366%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

7 January 2020

1007897425

0 references

1 reference